| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 749 | 333 | 584 | 3.161 | 4.187 | 4.513 |
| Total Income - EUR | - | - | - | - | 749 | 333 | 584 | 3.161 | 4.187 | 4.513 |
| Total Expenses - EUR | - | - | - | - | 400 | 160 | 328 | 267 | 1.639 | 2.377 |
| Gross Profit/Loss - EUR | - | - | - | - | 349 | 173 | 256 | 2.894 | 2.548 | 2.136 |
| Net Profit/Loss - EUR | - | - | - | - | 327 | 164 | 240 | 2.814 | 2.148 | 1.789 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Flaviped Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | 750 | 1.012 | 759 | 3.641 | 3.431 | 5.281 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 0 | 0 | 75 | 313 | 176 |
| Cash | - | - | - | - | 750 | 1.012 | 759 | 3.566 | 3.117 | 5.105 |
| Shareholders Funds | - | - | - | - | 369 | 526 | 755 | 3.571 | 2.215 | 3.992 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 382 | 486 | 4 | 70 | 1.216 | 1.290 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Flaviped Medical S.r.l.